Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Addictions Nursing|September 5, 2023
A Pathway to Treatment for Pregnant Women With Opioid Use DisorderRoshunya Shavon Clark, Jose A Pares-AvilaPancreas|March 1, 1996
Serum amino-terminal propeptide of type III procollagen levels in chronic pancreatitisS Navarro, R Valderrama, J M Lopez, et al.Acta Gastro-Enterologica Belgica|August 9, 2012
Familial primary biliary cirrhosis: like mother, like daughter?D S Smyk, E I Rigopoulou, A Pares, et al.Clinical Science (London, England : 1979)|December 1, 1992
Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats: effect of zinc administrationJ Camps, T Bargallo, A Gimenez, et al.Thorax|March 1, 1981
Pulmonary involvement in primary biliary cirrhosisR Rodriguez-Roisin, A Pares, M Bruguera, et al.Patient Education and Counseling|December 13, 2021
Efficacy of a language-concordant health coaching intervention for latinx with diabetesUsha Menon, Laura A Szalacha, Glenn A Martinez, et al.Journal of Hepatology|March 29, 2000
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic developmentK M Boberg, E Schrumpf, A Bergquist, et al.Journal of Viral Hepatitis|November 1, 2005
Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literatureM Ramos-Casals, A Pares, L-J Jara, et al.Gut|March 9, 2005
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosisE I Rigopoulou, E T Davies, A Pares, et al.Scandinavian Journal of Gastroenterology|November 1, 2002
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentationK M Boberg, A Bergquist, S Mitchell, et al.Pageof 2